Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
EQS-News: Biotest AG / Key word: Study results Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate 14.02.2024 / 08:30...
Comunidad Autonoma De Cataluna United States Silke Aigner Monika Baumann Buttkereit Dirk Neum Grifols Group
Source: marketscreener.com